NCT01525758 - Study of SI000413 in Knee Osteoarthritis Patients | Biotech Hunter

Enrollment

152

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions

Osteoarthritis, Knee

Interventions

DRUG

SI000413

1 Tablet = 200mg, (400mg, 600mg or 800mg vs. placebo) for 8weeks

DRUG

microcrystalline cellulose

identical number of tablets to active drug groups

Trial Locations (3)

RECRUITING

KyungHee University medical center, Seoul

RECRUITING

Ajou University Medical Center, Gyeonggi-do

RECRUITING

Seoul National University Hospital, Seoul